Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance

US11331051B2 · kind B2 · utility

Assignee

• ABBOTT DIABETES CARE INC. · US

Inventors

• Timothy Christian Dunn · San Francisco, US
• Kenneth J. Doniger · Menlo Park, US
• Glenn Berman · Alameda, US
• Gary Alan Hayter · Oakland, US
• Erwin Satrya Budiman · Fremont, US
• Daniel M. Bernstein · El Granada, US
• Nathan Crouther · San Francisco, US

Key dates

• Filing date: Dec 15, 2020
• Grant date: May 17, 2022
• Expiry date: Dec 15, 2040

Classification

• Technology area (CPC G): Physics
• CPC primary: G16H50/30
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.